Bordetella Pertussis Symposium,
EUPertStrain 2021
September 23rd, 2021 @ 9 AM (CET) | online
About
Bordetella Pertussis Symposium, EUPertStrain 2021, will take place online
EUPertStrain 2021 will be hosted by National Laboratory for Health, Environment and Food (NLZOH) from Ljubljana (Slovenia) on 22nd and 23rd September 2021.
The symposium will feature five topics:
- COVID-19 and Pertussis
- Epidemiology
- Diagnostics
- Biology and Evolution of Bordetella
- Vaccines and Immunology
History of the EUPertStrain network
The European network EUPertStrain was established in 2001 with the aims to improve pertussis surveillance and to study impact of Bordetella pertussis changes on vaccine effectiveness among European countries. It consists of many national reference laboratories and research laboratories in Europe. The network has published several expert consensus articles regarding the diagnosis of pertussis by PCR and serology, and epidemiological typing of B. pertussis. It provides an important platform for exchanging information in the field of pertussis at European level. The network has been coordinated by the Finnish National Reference Laboratory for Pertussis and Diphtheria at the University of Turku, Turku, Finland. The network has organized its annual meetings and EUPert serial studies.
1999 IP, Paris, France
2001 SMI, Stockholm, Sweden
2002 IP, Paris, France
2003 UTU/THL, Turku, Finland
2004 SMI, Stockholm, Sweden
2005 IP, Paris, France
2007 UTU/THL, Turku, Finland
2008 SSI, Copenhagen, Denmark
2009 ISS, Rome, Italy
2010 RIVM, Bilthoven, the Netherlands
2011 HPA, London, the UK
2012 NPHI, Oslo, Norway
2013 NIPH-NIH, Warsaw, Poland
2014 SSI, Copenhagen, Denmark
2015 UZ Brussel-WIV-ISP, Brussels, Belgium
2016 RIVM, Utrecht, The Netheralnds
2017 NPHI, Oslo, Norway
2018 SSI, Copenhagen, Denmark
2019 ISS, Rome, Italy
2020 IP, Paris, France
2021 National Laboratory for Health, Environment and Food
Book of Abstracts
EUPertStrain 2021 Book of Abstracts
Thank you for your participation.
Agenda
Sessions
COVID-19 and Pertussis | Epidemiology | Diagnostics | Biology and Evolution of Bordetella | Vaccines and Immunology |
Time | Speaker & Topic |
---|---|
9.00 – 9.10 | Welcome and introduction Welcome Speech by Tjaša Žohar Čretnik, Director of the National Laboratory for Environment, Health and Food |
Session 1: COVID-19 AND PERTUSSIS Chair Marta Grgič Vitek & Norman Fry | |
9.10-9.35 | Gayatri Amirthalingam – Evaluation of the impact and effectiveness of COVID-19 vaccination programme in the UK |
9.35-9.50 | Elise Tessier – The impact of the COVID-19 pandemic on Bordetella pertussis infections in England |
9.50-10.05 | Alex-Mikael Barkoff – How COVID-19 pandemic has affected to pertussis and three other respiratory diseases in Finland |
Session 2: EPIDEMIOLOGY Chair: Alex-Mikael Barkoff & Kevin Markey | |
10.05-10.20 | Sabrina Bacci – Pertussis surveillance in infants and seroprevalence studies in adults |
10:20-10.35 | Gro Tunheim – Antibody levels against vaccine-preventable diseases in children aged 10-13 years in Norway |
10.35-10.50 | Aapo Knuutila – How prevalent was pertussis in Finland 50 years ago? |
10.50-11.05 | Tamara Kastrin – Pertussis Surveillance in Slovenia |
11:05-11:15 | Coffee Break |
Session 3: DIAGNOSTICS Chair: Tamara Kastrin & Giorgio Fedele | |
11:15-11.30 | Kevin Markey – External Quality Assurance (EQA) Scheme for Bordetella pertussis serology 2020 |
11:30-11.45 | Aapo Knuutila – Simple and rapid lateral flow point-of-care assays for pertussis serology |
11.45-12.00 | Georgeta Cristina Oprea – Determination of IgG and IgA antibody titers against Bordetella pertussis virulence factors |
12.00-12.45 | Lunch break |
Session 4: BIOLOGY AND EVOLUTION OF BORDETELLA Chair: Sylvain Brisse & Paola Stefanelli | |
12.45-13.00 | Valérie Bouchez – Bystander vaccine-escape evolution of Bordetella parapertussis |
13.00-13.15 | Noémie Lefrancq – Estimating global spatial dynamics and vaccine induced fitness changes of Bordetella pertussis |
13.15-13.30 | Sébastien Bridel – Genomic library of Bordetella |
Session 5: VACCINES AND IMMUNOLOGY Chair: Qiushui He & Camille Locht | |
13.30-13.55 | Peter Sebo – ACT: potential vaccine antigen and for application of serological diagnosis |
13.55-14.10 | Giorgio Fedele – A comparative immunological study to define the next steps against a resurging disease |
14.10-14.25 | Stéphane Cauchi – Live attenuated pertussis vaccine for prevention and treatment of allergic asthma in mice |
14.25-14.40 | Violaine Dubois – Effect of maternal pertussis vaccination on nasal Bordetella pertussis carriage in the offspring |
14.40-14:55 | Pauline Versteegen – B cell activation induced by pertussis booster vaccination in four different age groups |
14.55-15.05 | Final conclusions Qiushui He/Tamara Kastrin – Future sights and next meeting |
Location
Building: Zoom
Room: Online
Address: Prvomajska ulica 1, 2000 Maribor, Slovenia